| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 2.17e-05 | 3 | 56 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 2.44e-05 | 21 | 56 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | TTLL12 CCNF SETDB2 RNF40 XPC XRCC3 ANKFN1 STAT5A STAT5B SPICE1 PCNT | 7.46e-05 | 1014 | 56 | 11 | GO:0000278 |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 1.49e-04 | 38 | 56 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | taurine metabolic process | 2.57e-04 | 9 | 56 | 2 | GO:0019530 | |
| GeneOntologyBiologicalProcess | pyrimidine dimer repair | 2.57e-04 | 9 | 56 | 2 | GO:0006290 | |
| GeneOntologyBiologicalProcess | alkanesulfonate metabolic process | 2.57e-04 | 9 | 56 | 2 | GO:0019694 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 2.60e-04 | 114 | 56 | 4 | GO:0033077 | |
| GeneOntologyBiologicalProcess | Schwann cell development | 2.82e-04 | 47 | 56 | 3 | GO:0014044 | |
| GeneOntologyBiologicalProcess | cerebellar cortex morphogenesis | 3.01e-04 | 48 | 56 | 3 | GO:0021696 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 3.21e-04 | 10 | 56 | 2 | GO:0060397 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 3.21e-04 | 10 | 56 | 2 | GO:0046543 | |
| GeneOntologyBiologicalProcess | body fluid secretion | 3.27e-04 | 121 | 56 | 4 | GO:0007589 | |
| GeneOntologyBiologicalProcess | regulation of centrosome duplication | 3.81e-04 | 52 | 56 | 3 | GO:0010824 | |
| GeneOntologyBiologicalProcess | negative regulation of erythrocyte differentiation | 3.92e-04 | 11 | 56 | 2 | GO:0045647 | |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 3.92e-04 | 11 | 56 | 2 | GO:0070669 | |
| GeneOntologyBiologicalProcess | Schwann cell differentiation | 4.50e-04 | 55 | 56 | 3 | GO:0014037 | |
| GeneOntologyBiologicalProcess | error-prone translesion synthesis | 4.70e-04 | 12 | 56 | 2 | GO:0042276 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 4.70e-04 | 12 | 56 | 2 | GO:0045588 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 4.70e-04 | 12 | 56 | 2 | GO:0032825 | |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 4.70e-04 | 12 | 56 | 2 | GO:0070672 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CCNF TCTE1 ERBB2 KIF27 SIK3 XRCC3 ANKFN1 AGTPBP1 SPICE1 PCNT | 4.99e-04 | 1058 | 56 | 10 | GO:0007017 |
| GeneOntologyBiologicalProcess | mucosa-associated lymphoid tissue development | 5.54e-04 | 13 | 56 | 2 | GO:0048537 | |
| GeneOntologyBiologicalProcess | Peyer's patch development | 5.54e-04 | 13 | 56 | 2 | GO:0048541 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 5.54e-04 | 13 | 56 | 2 | GO:0045136 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 5.54e-04 | 13 | 56 | 2 | GO:0038133 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 5.70e-04 | 249 | 56 | 5 | GO:0035264 | |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 5.81e-04 | 60 | 56 | 3 | GO:0021587 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 6.10e-04 | 61 | 56 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell activation | 6.45e-04 | 14 | 56 | 2 | GO:0046645 | |
| GeneOntologyBiologicalProcess | ERBB3 signaling pathway | 6.45e-04 | 14 | 56 | 2 | GO:0038129 | |
| GeneOntologyBiologicalProcess | regulation of centrosome cycle | 6.71e-04 | 63 | 56 | 3 | GO:0046605 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 7.02e-04 | 64 | 56 | 3 | GO:0021575 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell differentiation | 7.43e-04 | 15 | 56 | 2 | GO:0045586 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 7.67e-04 | 266 | 56 | 5 | GO:0045619 | |
| GeneOntologyBiologicalProcess | luteinization | 8.48e-04 | 16 | 56 | 2 | GO:0001553 | |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 9.51e-04 | 71 | 56 | 3 | GO:0021695 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell activation | 9.59e-04 | 17 | 56 | 2 | GO:0046643 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell differentiation | 1.08e-03 | 18 | 56 | 2 | GO:0021702 | |
| GeneOntologyBiologicalProcess | gamma-delta T cell differentiation | 1.33e-03 | 20 | 56 | 2 | GO:0042492 | |
| GeneOntologyBiologicalProcess | negative regulation of digestive system process | 1.33e-03 | 20 | 56 | 2 | GO:0060457 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer formation | 1.33e-03 | 20 | 56 | 2 | GO:0021694 | |
| Domain | STAT_TF_prot_interaction | 2.04e-04 | 7 | 59 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 2.04e-04 | 7 | 59 | 2 | IPR012345 | |
| Domain | STAT | 2.04e-04 | 7 | 59 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 2.04e-04 | 7 | 59 | 2 | IPR015988 | |
| Domain | - | 2.04e-04 | 7 | 59 | 2 | 2.60.40.630 | |
| Domain | STAT_int | 2.04e-04 | 7 | 59 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 2.04e-04 | 7 | 59 | 2 | IPR013801 | |
| Domain | STAT_bind | 2.04e-04 | 7 | 59 | 2 | PF02864 | |
| Domain | STAT_int | 2.04e-04 | 7 | 59 | 2 | PF02865 | |
| Domain | - | 2.04e-04 | 7 | 59 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 2.04e-04 | 7 | 59 | 2 | PF01017 | |
| Domain | - | 2.04e-04 | 7 | 59 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_alpha | 2.71e-04 | 8 | 59 | 2 | IPR013800 | |
| Domain | - | 6.74e-04 | 222 | 59 | 5 | 1.25.10.10 | |
| Domain | ARM-type_fold | 6.86e-04 | 339 | 59 | 6 | IPR016024 | |
| Domain | ARM-like | 1.61e-03 | 270 | 59 | 5 | IPR011989 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 4.60e-06 | 11 | 44 | 3 | MM15578 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.01e-05 | 14 | 44 | 3 | M27858 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.26e-05 | 15 | 44 | 3 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.26e-05 | 15 | 44 | 3 | M17681 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.54e-05 | 16 | 44 | 3 | M41733 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 2.65e-05 | 19 | 44 | 3 | M41732 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 2.65e-05 | 19 | 44 | 3 | M12836 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 3.12e-05 | 20 | 44 | 3 | MM1389 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 3.12e-05 | 20 | 44 | 3 | M39002 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 4.19e-05 | 22 | 44 | 3 | M7747 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 4.81e-05 | 23 | 44 | 3 | MM1411 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 4.81e-05 | 23 | 44 | 3 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 4.81e-05 | 23 | 44 | 3 | M7897 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 5.49e-05 | 24 | 44 | 3 | M11520 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 5.81e-05 | 68 | 44 | 4 | M39456 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 6.22e-05 | 25 | 44 | 3 | MM1519 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 6.22e-05 | 25 | 44 | 3 | M27865 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 7.02e-05 | 26 | 44 | 3 | M39687 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 7.02e-05 | 26 | 44 | 3 | MM15896 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 7.28e-05 | 72 | 44 | 4 | M39738 | |
| Pathway | BIOCARTA_GH_PATHWAY | 7.88e-05 | 27 | 44 | 3 | M9043 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 7.88e-05 | 27 | 44 | 3 | MM14712 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 8.80e-05 | 28 | 44 | 3 | M41724 | |
| Pathway | WP_PROLACTIN_SIGNALING | 8.99e-05 | 76 | 44 | 4 | M39601 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 9.46e-05 | 5 | 44 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 9.46e-05 | 5 | 44 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 9.46e-05 | 5 | 44 | 2 | M49006 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 9.80e-05 | 29 | 44 | 3 | M39616 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 9.80e-05 | 29 | 44 | 3 | M779 | |
| Pathway | PID_IL2_STAT5_PATHWAY | 1.09e-04 | 30 | 44 | 3 | M234 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.42e-04 | 6 | 44 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.42e-04 | 6 | 44 | 2 | MM15621 | |
| Pathway | PID_EPO_PATHWAY | 1.45e-04 | 33 | 44 | 3 | M233 | |
| Pathway | BIOCARTA_GH_PATHWAY | 1.45e-04 | 33 | 44 | 3 | MM1404 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 1.52e-04 | 87 | 44 | 4 | M12467 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 1.73e-04 | 35 | 44 | 3 | MM15144 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 1.89e-04 | 36 | 44 | 3 | MM1418 | |
| Pathway | PID_GMCSF_PATHWAY | 1.89e-04 | 36 | 44 | 3 | M22 | |
| Pathway | WP_ERBB_SIGNALING | 1.89e-04 | 92 | 44 | 4 | M39715 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 1.98e-04 | 7 | 44 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 1.98e-04 | 7 | 44 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 1.98e-04 | 7 | 44 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 1.98e-04 | 7 | 44 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 1.98e-04 | 7 | 44 | 2 | M27907 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 2.05e-04 | 37 | 44 | 3 | M8615 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 2.05e-04 | 37 | 44 | 3 | MM14564 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 2.22e-04 | 38 | 44 | 3 | M27536 | |
| Pathway | REACTOME_FLT3_SIGNALING | 2.22e-04 | 38 | 44 | 3 | M29803 | |
| Pathway | PID_ERBB4_PATHWAY | 2.22e-04 | 38 | 44 | 3 | M13 | |
| Pathway | WP_IL5_SIGNALING | 2.59e-04 | 40 | 44 | 3 | M39392 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 2.60e-04 | 100 | 44 | 4 | MM15826 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 2.78e-04 | 41 | 44 | 3 | MM15162 | |
| Pathway | WP_IL2_SIGNALING | 2.99e-04 | 42 | 44 | 3 | M39536 | |
| Pathway | PID_TCPTP_PATHWAY | 2.99e-04 | 42 | 44 | 3 | M91 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 3.21e-04 | 43 | 44 | 3 | MM15864 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 3.21e-04 | 43 | 44 | 3 | M508 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 3.38e-04 | 9 | 44 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 3.38e-04 | 9 | 44 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 3.38e-04 | 9 | 44 | 2 | M8066 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 3.44e-04 | 44 | 44 | 3 | M1012 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 3.92e-04 | 46 | 44 | 3 | MM15950 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 4.22e-04 | 10 | 44 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 4.22e-04 | 10 | 44 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 4.22e-04 | 10 | 44 | 2 | MM15618 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 4.45e-04 | 48 | 44 | 3 | M914 | |
| Pathway | WP_IL3_SIGNALING | 4.73e-04 | 49 | 44 | 3 | M39722 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 5.14e-04 | 11 | 44 | 2 | M27195 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 5.14e-04 | 11 | 44 | 2 | M29814 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 5.14e-04 | 11 | 44 | 2 | MM14760 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 6.16e-04 | 12 | 44 | 2 | M27893 | |
| Pathway | WP_IL4_SIGNALING | 6.30e-04 | 54 | 44 | 3 | M39720 | |
| Pathway | PID_IL2_1PATHWAY | 6.65e-04 | 55 | 44 | 3 | M122 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4 | 7.27e-04 | 13 | 44 | 2 | M39582 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 7.38e-04 | 57 | 44 | 3 | M19888 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.38e-04 | 57 | 44 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.77e-04 | 58 | 44 | 3 | M2049 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 8.16e-04 | 59 | 44 | 3 | M39350 | |
| Pathway | PID_IL5_PATHWAY | 8.46e-04 | 14 | 44 | 2 | M135 | |
| Pathway | WP_FOXP3_IN_COVID19 | 9.74e-04 | 15 | 44 | 2 | M42573 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 9.74e-04 | 15 | 44 | 2 | M552 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 9.74e-04 | 15 | 44 | 2 | MM14536 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 9.89e-04 | 63 | 44 | 3 | M635 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47381 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.11e-03 | 16 | 44 | 2 | MM15710 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 1.11e-03 | 16 | 44 | 2 | M562 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.11e-03 | 16 | 44 | 2 | MM1420 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 1.11e-03 | 16 | 44 | 2 | M29847 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 1.13e-03 | 66 | 44 | 3 | M39642 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 1.23e-03 | 68 | 44 | 3 | M48322 | |
| Pathway | WP_IL9_SIGNALING | 1.26e-03 | 17 | 44 | 2 | M39644 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.26e-03 | 17 | 44 | 2 | M47905 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 1.40e-03 | 71 | 44 | 3 | MM15947 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 1.41e-03 | 18 | 44 | 2 | M673 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 1.52e-03 | 73 | 44 | 3 | M321 | |
| Pathway | WP_EGFEGFR_SIGNALING | 1.60e-03 | 162 | 44 | 4 | M39334 | |
| Pathway | WP_LEPTIN_SIGNALING | 1.70e-03 | 76 | 44 | 3 | M39491 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 1.75e-03 | 20 | 44 | 2 | MM15496 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 2.11e-03 | 22 | 44 | 2 | M26929 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 2.31e-03 | 23 | 44 | 2 | MM1480 | |
| Pubmed | Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. | 1.48e-07 | 28 | 59 | 4 | 19661089 | |
| Pubmed | Distribution of the mammalian Stat gene family in mouse chromosomes. | 1.31e-06 | 13 | 59 | 3 | 8530075 | |
| Pubmed | SETDB2 ERBB2 EP400 OAS3 XPC PPP6R1 SIK3 REV3L ELL3 AGTPBP1 SOS1 | 2.41e-06 | 1116 | 59 | 11 | 31753913 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23151802 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26999798 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 2.83e-06 | 2 | 59 | 2 | 20233708 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21986939 | ||
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 2.83e-06 | 2 | 59 | 2 | 16775227 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 2.83e-06 | 2 | 59 | 2 | 31443474 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17447893 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12377952 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 27481099 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 2.83e-06 | 2 | 59 | 2 | 21127177 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 16289657 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25552366 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25470773 | ||
| Pubmed | DNA polymerase ζ generates tandem mutations in immunoglobulin variable regions. | 2.83e-06 | 2 | 59 | 2 | 22615128 | |
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 2.83e-06 | 2 | 59 | 2 | 21431790 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 16115927 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23275557 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 28500076 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21826656 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 11867689 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 7720707 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26727495 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 2.83e-06 | 2 | 59 | 2 | 15980098 | |
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 2.83e-06 | 2 | 59 | 2 | 27264955 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 15340066 | ||
| Pubmed | Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells. | 2.83e-06 | 2 | 59 | 2 | 26648017 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 22159083 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 20008792 | ||
| Pubmed | Erbb2 up-regulation of ADAM12 expression accelerates skin cancer progression. | 2.83e-06 | 2 | 59 | 2 | 24798404 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 33199496 | ||
| Pubmed | STAT5A/B gene locus undergoes amplification during human prostate cancer progression. | 2.83e-06 | 2 | 59 | 2 | 23660011 | |
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 2.83e-06 | 2 | 59 | 2 | 12901872 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 28074064 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 36755813 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 16502315 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12217382 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25333863 | ||
| Pubmed | A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. | 2.83e-06 | 2 | 59 | 2 | 12421978 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 9852045 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 31599926 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19966185 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21704724 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 10594041 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 21036145 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 10486277 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 38618957 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 2.83e-06 | 2 | 59 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 2.83e-06 | 2 | 59 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 2.83e-06 | 2 | 59 | 2 | 30377054 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 2.83e-06 | 2 | 59 | 2 | 32790723 | |
| Pubmed | Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. | 2.83e-06 | 2 | 59 | 2 | 8732682 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 18492722 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26717567 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 10066807 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 10835485 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 35464049 | ||
| Pubmed | The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5. | 2.83e-06 | 2 | 59 | 2 | 32281944 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 2.83e-06 | 2 | 59 | 2 | 23773921 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 2.83e-06 | 2 | 59 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 2.83e-06 | 2 | 59 | 2 | 24878107 | |
| Pubmed | Adipocyte STAT5 deficiency does not affect blood glucose homeostasis in obese mice. | 2.83e-06 | 2 | 59 | 2 | 34818373 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12847485 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12835478 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 2.83e-06 | 2 | 59 | 2 | 24497979 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23465551 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 11756158 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 2.83e-06 | 2 | 59 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 2.83e-06 | 2 | 59 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 2.83e-06 | 2 | 59 | 2 | 10486314 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 2.83e-06 | 2 | 59 | 2 | 24497923 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29203513 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 27367207 | ||
| Pubmed | Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. | 2.83e-06 | 2 | 59 | 2 | 16493008 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 24335105 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8816482 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 2.83e-06 | 2 | 59 | 2 | 29460051 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 10851057 | ||
| Pubmed | Genome-wide regulation of electro-acupuncture on the neural Stat5-loss-induced obese mice. | 2.83e-06 | 2 | 59 | 2 | 28806763 | |
| Pubmed | Critical functions for STAT5 tetramers in the maturation and survival of natural killer cells. | 2.83e-06 | 2 | 59 | 2 | 29105654 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17003334 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17438530 | ||
| Pubmed | Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors. | 2.83e-06 | 2 | 59 | 2 | 15677477 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 16757175 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 15677453 | ||
| Pubmed | Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas. | 2.83e-06 | 2 | 59 | 2 | 15870688 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 28606561 | ||
| Pubmed | Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. | 2.83e-06 | 2 | 59 | 2 | 19833766 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 17317776 | ||
| Pubmed | Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis. | 2.83e-06 | 2 | 59 | 2 | 20415542 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 23332799 | ||
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 2.83e-06 | 2 | 59 | 2 | 12393407 | |
| GeneFamily | WD repeat domain containing|Xeroderma pigmentosum complementation groups|Nucleotide excision repair | 1.33e-04 | 8 | 40 | 2 | 1125 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.88e-08 | 155 | 59 | 6 | 335cd798afbaa0a3a3e1dc558a81cfa32da48983 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.11e-08 | 156 | 59 | 6 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.91e-06 | 168 | 59 | 5 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.80e-06 | 200 | 59 | 5 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| Computational | Neighborhood of PPP5C | 1.84e-04 | 91 | 34 | 4 | MORF_PPP5C | |
| Disease | Xeroderma Pigmentosum | 2.12e-05 | 4 | 56 | 2 | C0043346 | |
| Disease | xeroderma pigmentosum (implicated_via_orthology) | 5.28e-05 | 6 | 56 | 2 | DOID:0050427 (implicated_via_orthology) | |
| Disease | invasive lobular carcinoma (is_marker_for) | 7.38e-05 | 7 | 56 | 2 | DOID:3457 (is_marker_for) | |
| Disease | Xeroderma pigmentosum | 1.26e-04 | 9 | 56 | 2 | cv:C0043346 | |
| Disease | Basal cell carcinoma | 1.92e-04 | 11 | 56 | 2 | C0007117 | |
| Disease | campesterol measurement | 1.92e-04 | 11 | 56 | 2 | EFO_0020008 | |
| Disease | Adenocarcinoma of lung (disorder) | 6.38e-04 | 206 | 56 | 4 | C0152013 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.12e-03 | 26 | 56 | 2 | DOID:234 (is_implicated_in) | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.30e-03 | 28 | 56 | 2 | DOID:3717 (is_marker_for) | |
| Disease | Pigmented Basal Cell Carcinoma | 1.30e-03 | 28 | 56 | 2 | C1368275 | |
| Disease | Carcinoma, Basal Cell | 1.39e-03 | 29 | 56 | 2 | C4721806 | |
| Disease | Carcinoma, Granular Cell | 1.41e-03 | 116 | 56 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.41e-03 | 116 | 56 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.41e-03 | 116 | 56 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.41e-03 | 116 | 56 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.41e-03 | 116 | 56 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.41e-03 | 116 | 56 | 3 | C0001418 | |
| Disease | Head and Neck Neoplasms | 1.80e-03 | 33 | 56 | 2 | C0018671 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IAHNQVRQVPLQRLR | 86 | P04626 | |
| NVLSILVRLQRICNH | 1356 | Q96L91 | |
| QLEHVQTRLREIQPC | 876 | O75150 | |
| HQRCTVTRPEQLLLQ | 1011 | Q5SNV9 | |
| ALQECQRQQVRPVIA | 36 | Q9HB65 | |
| LEICHPQERNIFNRI | 296 | Q9Y305 | |
| PQLVRKCVAHVRQHN | 141 | Q9H221 | |
| RIAFQQHRRPLIQCL | 831 | A6QL63 | |
| RLLQCQNVDISRPLN | 791 | O43184 | |
| VKQNLQNHRLVLPCL | 166 | Q9UPW5 | |
| QNHRLVLPCLQLLRV | 171 | Q9UPW5 | |
| QQVFPVHEQRILNRL | 206 | Q9HCE9 | |
| LCNVRQQAIPASHNI | 786 | Q09MP3 | |
| QPILRFLQLLCENHN | 1871 | Q14573 | |
| INRRKRLVQLPCHTN | 116 | P0C860 | |
| RPRIVCLNQLGKHVQ | 1411 | Q7Z5J8 | |
| SQPCVHLQAQIQIRV | 166 | P34810 | |
| ELCIQHIIRNFQKNP | 81 | Q5JU00 | |
| RIPQARALLQQCLHA | 6 | Q96FN9 | |
| LHNHQVCVRVIPNSQ | 21 | Q86VH2 | |
| VLLQRLEPVHLQLQC | 341 | Q96PD5 | |
| ALVANIIQNVPVHQR | 1046 | O94915 | |
| QACRLVPLNQNHLVS | 81 | Q6AI08 | |
| SLQRQQQPEAALLRC | 206 | Q1L5Z9 | |
| RQLQVLHQRFLRCQV | 1931 | O95613 | |
| ICRIVCRHAQQIALQ | 216 | P46089 | |
| SSHPIIRQIRQACAQ | 46 | Q9BSY4 | |
| FCNAVIQVAHPLIRN | 291 | Q05DH4 | |
| PQQQVKRINLCIHSE | 761 | P41002 | |
| LIQCNQDQPDRIHLL | 406 | Q9NQT6 | |
| LNLHRPTCIVRAQNG | 146 | P18847 | |
| QISHDIRQRNKCLPI | 671 | O75342 | |
| RNPQVHQRVSECLRV | 181 | Q99487 | |
| RTVLGLVQQHQQLCV | 656 | Q9Y6K5 | |
| VRHICLEGQLIRVNQ | 2061 | Q6ZRI0 | |
| VQNHCRQIPAVLRQL | 991 | Q6ZUA9 | |
| ACHNQHLQLQPPRRR | 196 | Q9NPB1 | |
| IPSLQQLHLQRNALC | 66 | Q9C0I9 | |
| QLHLQRNALCVIPQD | 71 | Q9C0I9 | |
| CENQPALLTHQLQRL | 711 | Q9Y2K2 | |
| QQIRRAEHLCQQLPI | 291 | P51692 | |
| CFFVQVEQRQNPHLR | 16 | Q9Y253 | |
| YIQPVQLRVLNVCRH | 681 | Q07889 | |
| QCLQHIPVNEENRRS | 91 | O75570 | |
| CRQVISQLPRCHRNV | 821 | Q01968 | |
| LTHAIKNCPVINNRQ | 446 | Q8N0Z3 | |
| QQIRRAEHLCQQLPI | 291 | P42229 | |
| LQQINIPLHQARNFR | 691 | Q8N957 | |
| HPQLKQCVRQAIERA | 1386 | A5YKK6 | |
| LQAVINEVCRHRPLN | 271 | Q9BYD6 | |
| CQNRVVQHGPQVRLQ | 356 | Q96T68 | |
| KCRSQPQHVAVILNQ | 3056 | O60673 | |
| LAHPCIVLRRQCQVN | 116 | Q96AG3 | |
| VSQPRRNIVGCRIQH | 46 | Q9Y657 | |
| QLFHRCQRAVQALPS | 131 | O14662 | |
| PVQRAAICQNLQHVL | 276 | Q96HA7 | |
| AICQNLQHVLAVVRL | 281 | Q96HA7 | |
| CRVEHARQQLQQVPG | 126 | Q14166 | |
| QNPVVKHLLQQCRLV | 426 | Q9UPN7 | |
| QNEQCRRLHVPELLV | 421 | Q6ZR37 | |
| CVQLNLPNLHRVARK | 771 | Q01831 | |
| LALQLCLAVQFPRQH | 116 | O43542 | |
| ALAQQQVRRTPAQCR | 101 | Q5T230 | |
| HVRQQLLQRKPQQHC | 546 | Q9BYP7 |